s6y Cronos Group Inc. 40-F

Cronos Group Inc. 40-F, filed Apr 30, 2018: IDEA: XBRL DOCUMENT

Stock-based payments
12 Months Ended
Dec. 31, 2017
Text block1 [abstract]  
Stock-based payments
16.

Stock-based payments

(a)

Option plan details

The Company has an incentive stock option plan, under which non-transferrable options to purchase common shares of the Company may be granted to directors, officers, employees, or consultants of the Company. The terms of the plan provide that the Board of Directors may grant options to acquire common shares of the Company at not less than the discounted market price (as set out in the plan) with the market price deemed to be the closing price on the day preceding the grant at varying rates. The maximum number of common shares reserved for issuance for options that may be granted under the plan is 10% of the common shares outstanding. No amounts are paid or payable by the recipient on receipt of the option, and the Board of Directors has the authority to determine the terms, limitations, restrictions, and conditions (including any criteria) in respect of any grants.

(b)

Summary of changes

The following is a summary of the changes in options for the period from January 1, 2016 to December 31, 2016:

  Grant date   Exercise price   Number of
options
  Amount  

Balance at January 1, 2016

  1,610,003   $ 599  

Issuance of options

May

  May 17 and 27, 2016   $ 0.285     157,850     6  

August

  August 5, 2016     0.50     1,225,000     30  

October

  October 6, 2016     1.23     3,618,500     114  

November

  Multiple     Multiple     482,000     28  

Exercise of options

  —    

August

  October 1, 2013     0.24     (213,390 )    (31 ) 

August

  May 17 and 27, 2016     0.285     (157,390 )    (6 ) 

October

  October 1, 2013     0.24     (32,008 )    (5 ) 

Expiry of options

  0.96     (512,971 )    —    

 

 

Balance at December 31, 2016

  6,177,594   $ 735  

 

 

The following is a summary of the changes in options for the period from January 1, 2017 to December 31, 2017:

  Grant date   Exercise price   Number of
options
  Amount  

Balance at January 1, 2017

  6,177,594   $ 735  

Issuance of options

April

  April 12, 2017     3.14     3,299,000     —    

August

  August 23, 2017     2.42     2,903,000     —    

November

  November 9, 2017     3.32     200,000     —    

Exercise of options

January

  January 30, 2014     0.71     (32,009 )    (14 ) 

February

  August 5, 2014     1.15     (32,000 )    (23 ) 

March

  September 19, December 17, 2014     1.15     (171,695 )    (104 ) 

April

  August 5, 2014     1.15     (93,000 )    (66 ) 

April

  October 6, 2016     1.23     (30,416 )    (15 ) 

May

  August 5, 2014     1.15     (35,043 )    (25 ) 

July

  August 5, 2016     0.50     (83,333 )    (19 ) 

September

  October 6, 2016     1.23     (1,250 )    (1 ) 

December

  December 17, 2014     1.15     (92,500 )    (41 ) 

Expiry of options

  (404,598 )    —    

Vesting of issued options

  1.15     —       1,862  

 

 

Balance at December 31, 2017

  11,603,750   $ 2,289  

 

 

The weighted average share price at the dates of exercise of options during the year ended December 31, 2017 was $3.66 (2016 - $0.52).

As at December 31, 2017, the Company had outstanding and exercisable options as follows:

          Weighted average  

Grant date

Vesting terms   Number of
options
  Exercise price   Remaining
contractual life
(years)
 

August 5, 2016

  Evenly over 48 months     1,141,666   $ 0.50     3.60  

October 6, 2016

  Evenly over 48 months     3,578,084     1.23     3.77  

November 16, 2016

  On May 15, 2017     300,000     1.50     0.37  

November 21, 2016

  Evenly over 48 months     182,000     1.84     3.88  

April 12, 2017

  Evenly over 48 months     3,299,000     3.14     4.28  

August 23, 2017

  Evenly over 48 months     2,903,000     2.42     4.65  

November 9, 2017

  Evenly over 48 months     200,000     3.32     4.86  

 

 

 

Outstanding at December 31, 2017

  11,603,750   $ 2.05     4.05  

 

 

 

Exercisable at December 31, 2017

  2,744,387   $ 1.71     3.57  

 

 

 

These options shall expire at the earlier of 180 days of the death, disability or incapacity of the holder or five years after the date of issue, and can only be settled in equity.

As at December 31, 2017, the weighted average exercise price of options outstanding is $2.05 (2016 - $1.10). The weighted average exercise price of options exercisable is $1.71 (2016 - $1.09).

(c)

Fair Value of Options Issued During the Year

The fair value of the options was determined using the Black-Scholes option pricing model. The following inputs were used:

  2017   2016

Share price at grant date

$2.42 - $3.27   $0.19 - $1.77

Exercise price

$2.42 - $3.32   $0.285 - $1.84

Risk free interest rate

0.96% - 1.59%   0.54% - 0.67%

Expected life of options (years)

5   0.25 - 5

Expected annualized volatility

55%   55% - 150%

Expected dividend yield

0%   0%

Weighted average Black Scholes value at grant date

$1.39   $0.43

Volatility was estimated using the historical volatility of the Company and other companies that the Company considers comparable that have trading and volatility history prior to the Company becoming public.

(d)

Expenses Arising from Stock-based Payments

Total expenses arising from stock-based payments recognized during the year ended December 31, 2017 were $1,862 (2016 $307).